Sections
| Title | Starting Page | Number of Pages |
|---|
| Cover Page | 1 | 1 |
| List of Contents and Tables | 2 | 1 |
| 2025 DEVELOPMENTS | 2 | 1 |
| PROSPECTS and OPPORTUNITIES | 2 | 1 |
| CATEGORY DATA | 2 | 1 |
| Table/Chart: 2 | 2 | 1 |
| Table/Chart: Tabular Data Analysis | 2 | 1 |
| Graph - Graph/Chart Analysis | 3 | 1 |
| Analgesics in Tunisia - Category Analysis | 4 | 1 |
| KEY DATA FINDINGS | 4 | 1 |
| 2025 DEVELOPMENTS | 4 | 1 |
| Profit margins fall | 4 | 1 |
| Sanofi-aventis continues to lead, gaining further value share in 2025 | 4 | 1 |
| Pharmacies hold monopoly | 4 | 1 |
| PROSPECTS and OPPORTUNITIES | 4 | 1 |
| ANALGESICS IN TUNISIA | 5 | 1 |
| Further fall in constant value sales over forecast period | 5 | 1 |
| Little innovation, as price controls stifle competition | 5 | 1 |
| Private sector pushes for deregulation | 5 | 1 |
| CATEGORY DATA | 5 | 1 |
| Table/Chart: Table 1 Sales of Analgesics by Category: Value 2020-2025 | 5 | 1 |
| Table/Chart: Tabular Data Analysis | 5 | 1 |
| ANALGESICS IN TUNISIA | 6 | 1 |
| Table 2 Sales of Analgesics by Category: % Value Growth 2020-2025 | 6 | 1 |
| Table/Chart: Analgesics | 6 | 1 |
| Table/Chart: Tabular Data Analysis | 6 | 1 |
| Table/Chart: % current value growth | 6 | 1 |
| ANALGESICS IN TUNISIA | 7 | 1 |
| Table/Chart: Table 3 NBO Company Shares of Analgesics: % Value 2021-2025 | 7 | 1 |
| Table/Chart: Tabular Data Analysis | 7 | 1 |
| Table/Chart: Table 4 LBN Brand Shares of Analgesics: % Value 2022-2025 | 7 | 1 |
| ANALGESICS IN TUNISIA | 8 | 1 |
| Table/Chart: Tabular Data Analysis | 8 | 1 |
| Table/Chart: Table 5 Forecast Sales of Analgesics by Category: Value 2025-2030 | 8 | 1 |
| ANALGESICS IN TUNISIA | 9 | 1 |
| Table/Chart: Tabular Data Analysis | 9 | 1 |
| Table/Chart: Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2025-2030 | 9 | 1 |
| ANALGESICS IN TUNISIA | 10 | 1 |
| Graph - Note: 2025 data is provisional and based on part-year estimates | 10 | 1 |
| Consumer Health in Tunisia - Industry Overview | 11 | 1 |
| EXECUTIVE SUMMARY | 11 | 1 |
| Key trends in 2025 | 11 | 1 |
| Competitive landscape | 11 | 1 |
| Channel developments | 11 | 1 |
| ANALGESICS IN TUNISIA | 12 | 1 |
| What next for consumer health? | 12 | 1 |
| MARKET INDICATORS | 12 | 1 |
| Table/Chart: Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2020-2025 | 12 | 1 |
| Table/Chart: Tabular Data Analysis | 12 | 1 |
| ANALGESICS IN TUNISIA | 13 | 1 |
| MARKET DATA | 13 | 1 |
| Table 9 Sales of Consumer Health by Category: Value 2020-2025 | 13 | 1 |
| Table 10 Sales of Consumer Health by Category: % Value Growth 2020-2025 | 13 | 1 |
| Table/Chart: Table 8 Life Expectancy at Birth 2020-2025 | 13 | 1 |
| Table/Chart: Tabular Data Analysis | 13 | 1 |
| Table/Chart: TND million | 13 | 1 |
| Table/Chart: % current value growth | 13 | 1 |
| ANALGESICS IN TUNISIA | 14 | 1 |
| Table/Chart: Table 11 NBO Company Shares of Consumer Health: % Value 2021-2025 | 14 | 1 |
| Table/Chart: Tabular Data Analysis | 14 | 1 |
| Table/Chart: Table 12 LBN Brand Shares of Consumer Health: % Value 2022-2025 | 14 | 1 |
| ANALGESICS IN TUNISIA | 15 | 1 |
| Table/Chart: Tabular Data Analysis | 15 | 1 |
| ANALGESICS IN TUNISIA | 16 | 1 |
| Table 14 Distribution of Consumer Health by Format and Category: % Value 2025 | 16 | 1 |
| Table/Chart: Table 13 Distribution of Consumer Health by Format: % Value 2020-2025 | 16 | 1 |
| Table/Chart: Tabular Data Analysis | 16 | 1 |
| Table/Chart: % retail value rsp | 16 | 1 |
| ANALGESICS IN TUNISIA | 17 | 1 |
| Table/Chart: Tabular Data Analysis | 17 | 1 |
| ANALGESICS IN TUNISIA | 18 | 1 |
| Table 15 Forecast Sales of Consumer Health by Category: Value 2025-2030 | 18 | 1 |
| Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030 | 18 | 1 |
| Table/Chart: Tabular Data Analysis | 18 | 1 |
| Table/Chart: TND million | 18 | 1 |
| Table/Chart: % constant value growth | 18 | 1 |
| ANALGESICS IN TUNISIA | 19 | 1 |
| APPENDIX | 19 | 1 |
| Otc registration and classification | 19 | 1 |
| Vitamins and dietary supplements registration and classification | 19 | 1 |
| Table/Chart: Tabular Data Analysis | 19 | 1 |
| Disclosure | 20 | 1 |
| Disclosure | 21 | 1 |
| Graph - Source: Euromonitor International | 21 | 1 |
| Table/Chart: Summary 1 Research Sources | 21 | 1 |
| Table/Chart: Tabular Data Analysis | 21 | 1 |
